Skip to main content
SpringerLink
Log in

Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The aim of this study was to investigate the possible beneficial effects of Fenofibrate on renal ischemia-reperfusion injury (IRI) in mice and its potential mechanism. IRI was induced by bilateral renal ischemia for 60 min followed by reperfusion for 24 h. Eighteen male C57BL/6 mice were randomly divided into three groups: sham-operated group (sham), IRI+saline group (IRI group), IRI+Fenofibrate (FEN) group. Normal saline or Fenofibrate (3 mg/kg) was intravenously injected 60 min before renal ischemia in IRI group and FEN group, respectively. Blood samples and renal tissues were collected at the end of reperfusion. The renal function, histopathologic changes, and the expression levels of pro-inflammatory cytokines [interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-α) and IL-6] in serum and renal tissue homogenate were assessed. Moreover, the effects of Fenofibrate on activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling and peroxisome proliferator-activated receptor-α (PPAR-α) were also measured in renal IRI. The results showed that plasma levels of blood urea nitrogen and creatinine, histopathologic scores and the expression levels of TNF-α, IL-8 and IL-6 were significantly lower in FEN group than in IRI group. Moreover, Fenofibrate pretreatment could further induce PI3K/Akt signal pathway and PPAR-α activation following renal IRI. These findings indicated PPAR-α activation by Fenofibrate exerts protective effects on renal IRI in mice by suppressing inflammation via PI3K/Akt activation. Thus, Fenofibrate could be a novel therapeutic alternative in renal IRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med, 1998, 128(3):194–203

    Article  CAS  PubMed  Google Scholar 

  2. Aydin Z, van Zonneveld AJ, de Fijter JW, et al. New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant, 2007, 22(2):342–346

    Article  PubMed  Google Scholar 

  3. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol, 2005, 16(11):3365–3370

    Article  PubMed  Google Scholar 

  4. Kazmers A, Jacobs L, Perkins A. The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res, 1997, 67(1):62–66

    Article  CAS  PubMed  Google Scholar 

  5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA, 1996, 275(19):1489–1494

    Article  CAS  PubMed  Google Scholar 

  6. Zhang J, Li JH, Wang L, et al. Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(4):516–520

    Article  PubMed  Google Scholar 

  7. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med, 2002, 346(5): 305–310

    Article  PubMed  Google Scholar 

  8. Amura CR, Renner B, Lyubchenko T, et al. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol, 2012, 52(3–4):249–257

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Fan LH, He L, Cao ZQ, et al. Effect of ischemia preconditioning on renal ischemia/reperfusion injury in rats. Int Braz J Urol, 2012, 38(6):842–854

    Article  PubMed  Google Scholar 

  10. Kusch A, Hoff U, Bubalo G, et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf), 2013, 208(1):25–40

    Article  CAS  Google Scholar 

  11. Kim HJ, Joe Y, Kong JS, et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev, 2013, 2013:306421

    PubMed Central  PubMed  Google Scholar 

  12. Hofmann BT, Jucker M. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85alpha regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Cell Signal, 2012, 24(10):1950–1954

    Article  CAS  PubMed  Google Scholar 

  13. Chen L, Wei X, Hou Y, et al. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3beta pathway in rats. Neurochem Int, 2014, 66:27–32

    Article  CAS  PubMed  Google Scholar 

  14. Rasin MS. Peroxisome proliferator-activated receptors-gamma and hypertension: lessons of the history of researches. Ter Arkh, 2013, 85(9):118–123

    CAS  PubMed  Google Scholar 

  15. Guebre-Egziabher F, Alix PM, Koppe L, et al. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie, 2013, 95(11):1971–1979

    Article  CAS  PubMed  Google Scholar 

  16. Bulhak AA, Jung C, Ostenson CG, et al. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol, 2009, 296(3):H719–727

    Article  CAS  PubMed  Google Scholar 

  17. Patel NS, di Paola R, Mazzon E, et al. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J Pharmacol Exp Ther, 2009, 328(2):635–643.

    Article  CAS  PubMed  Google Scholar 

  18. Dong C, Hu Y, Wang H, et al. Inhibitory effects of fenofibrate on plasminogen activator inhibitor-1 expression in human endothelial cells. Huazhong Univ Sci Technolog Med Sci, 2006, 26(2):192–193

    Article  CAS  Google Scholar 

  19. Retraction note: Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, on hepatic ischemia-reperfusion injury in rats. J Mol Histol, 2013, 44(4):495

    Google Scholar 

  20. Yang C, Zhao T, Lin M, et al. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood), 2013, 238(1):111–119

    Article  CAS  Google Scholar 

  21. Xie L, Zheng X, Qin J, et al. Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton), 2006, 11(3):207–212

    Article  CAS  Google Scholar 

  22. Liu WH, Liu HB, Gao DK, et al. ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway. Cell Transplant, 2013, 22(10):1859–1868

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Feng-jie Yang  (杨凤杰), Yong-hua He  (何永华) & Jian-hua Zhou  (周建华)

Authors
  1. Feng-jie Yang  (杨凤杰)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong-hua He  (何永华)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-hua Zhou  (周建华)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian-hua Zhou  (周建华).

Additional information

This project was supported by the National Natural Science Foundation of China (No. 81070557).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Fj., He, Yh. & Zhou, Jh. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 35, 58–63 (2015). https://doi.org/10.1007/s11596-015-1389-2

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-015-1389-2

Key words

Search

Navigation